Mutations in Dihydropteroate Synthase Are Responsible for Sulfone and Sulfonamide Resistance in Plasmodium Falciparum

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1998 Feb 12

PMID 9391132

Citations 158

Authors

T Triglia

J G Menting

C Wilson

A F Cowman

Affiliations

Soon will be listed here.

Abstract

Plasmodium falciparum causes the most severe form of malaria in humans. An important class of drugs in malaria treatment is the sulfone/sulfonamide group, of which sulfadoxine is the most commonly used. The target of sulfadoxine is the enzyme dihydropteroate synthase (DHPS), and sequencing of the DHPS gene has identified amino acid differences that may be involved in the mechanism of resistance to this drug. In this study we have sequenced the DHPS gene in 10 isolates from Thailand and identified a new allele of DHPS that has a previously unidentified amino acid difference. We have expressed eight alleles of P. falciparum PPPK-DHPS in Escherichia coli and purified the functional enzymes to homogeneity. Strikingly, the Ki for sulfadoxine varies by almost three orders of magnitude from 0.14 microM for the DHPS allele from sensitive isolates to 112 microM for an enzyme expressed in a highly resistant isolate. Comparison of the Ki of different sulfonamides and the sulfone dapsone has suggested that the amino acid differences in DHPS would confer cross-resistance to these compounds. These results show that the amino acid differences in the DHPS enzyme of sulfadoxine-resistant isolates of P. falciparum are central to the mechanism of resistance to sulfones and sulfonamides.

Citing Articles

Genome sequencing of Plasmodium malariae identifies continental segregation and mutations associated with reduced pyrimethamine susceptibility.

Ibrahim A, Mohring F, Manko E, van Schalkwyk D, Phelan J, Nolder D Nat Commun. 2024; 15(1):10779.

PMID: 39738025 PMC: 11685946. DOI: 10.1038/s41467-024-55102-3.

Geo-classification of drug-resistant travel-associated using and gene sequences (USA, 2018-2021).

Pierre-Louis E, Kelley J, Patel D, Carlson C, Talundzic E, Jacobson D Antimicrob Agents Chemother. 2024; 68(12):e0120324.

PMID: 39530682 PMC: 11619247. DOI: 10.1128/aac.01203-24.

Prevalence of molecular markers of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from West Africa during 2012-2022.

Zhou R, Li S, Ji P, Ruan S, Liu Y, Yang C Sci Rep. 2024; 14(1):26567.

PMID: 39496624 PMC: 11535326. DOI: 10.1038/s41598-024-75828-w.

To quest new targets of parasite and their potential inhibitors to combat antimalarial drug resistance.

Biswas P, Roy R, Ghosh K, Nath D, Samadder A, Nandi S J Parasit Dis. 2024; 48(4):671-722.

PMID: 39493470 PMC: 11527868. DOI: 10.1007/s12639-024-01687-x.

Evolution of Pfdhps and Pfdhfr mutations before and after adopting seasonal malaria chemoprevention in Nanoro, Burkina Faso.

Bohissou F, Sondo P, Inoue J, Rouamba T, Kabore B, Nassa G Sci Rep. 2024; 14(1):24224.

PMID: 39414909 PMC: 11484836. DOI: 10.1038/s41598-024-75369-2.

References

FERONE R . The enzymic synthesis of dihydropteroate and dihydrofolate by Plasmodium berghei. J Protozool. 1973; 20(3):459-64. DOI: 10.1111/j.1550-7408.1973.tb00926.x. View

WATKINS W, Sixsmith D, Chulay J, SPENCER H . Antagonism of sulfadoxine and pyrimethamine antimalarial activity in vitro by p-aminobenzoic acid, p-aminobenzoylglutamic acid and folic acid. Mol Biochem Parasitol. 1985; 14(1):55-61. DOI: 10.1016/0166-6851(85)90105-7. View

Walter R, Konigk E . 7,8-Dihydropteroate-synthesizing enzyme from Plasmodium chabaudi. Methods Enzymol. 1980; 66:564-70. DOI: 10.1016/0076-6879(80)66508-2. View

FERONE R . Dihydrofolate reductase from pyrimethamine-resistant Plasmodium berghei. J Biol Chem. 1970; 245(4):850-4. View

Allegra C, Boarman D, Kovacs J, Morrison P, Beaver J, Chabner B . Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase. J Clin Invest. 1990; 85(2):371-9. PMC: 296434. DOI: 10.1172/JCI114448. View

Landgraf B, Kollaritsch H, WIEDERMANN G, Wernsdorfer W . Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren. Trans R Soc Trop Med Hyg. 1994; 88(4):440-2. DOI: 10.1016/0035-9203(94)90424-3. View

Cowman A, KARCZ S, Galatis D, Culvenor J . A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. J Cell Biol. 1991; 113(5):1033-42. PMC: 2289011. DOI: 10.1083/jcb.113.5.1033. View

Chulay J, WATKINS W, Sixsmith D . Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro. Am J Trop Med Hyg. 1984; 33(3):325-30. DOI: 10.4269/ajtmh.1984.33.325. View

Peterson D, Walliker D, Wellems T . Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci U S A. 1988; 85(23):9114-8. PMC: 282674. DOI: 10.1073/pnas.85.23.9114. View

10.

Cowman A, Morry M, Biggs B, Cross G, Foote S . Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc Natl Acad Sci U S A. 1988; 85(23):9109-13. PMC: 282673. DOI: 10.1073/pnas.85.23.9109. View

11.

Krungkrai J, Webster H, Yuthavong Y . De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol. 1989; 32(1):25-37. DOI: 10.1016/0166-6851(89)90126-6. View

12.

Fermer C, Kristiansen B, SKOLD O, Swedberg G . Sulfonamide resistance in Neisseria meningitidis as defined by site-directed mutagenesis could have its origin in other species. J Bacteriol. 1995; 177(16):4669-75. PMC: 177231. DOI: 10.1128/jb.177.16.4669-4675.1995. View

13.

Brown G . The biosynthesis of pteridines. Adv Enzymol Relat Areas Mol Biol. 1971; 35:35-77. DOI: 10.1002/9780470122808.ch2. View

14.

Lopez P, Espinosa M, Greenberg B, Lacks S . Sulfonamide resistance in Streptococcus pneumoniae: DNA sequence of the gene encoding dihydropteroate synthase and characterization of the enzyme. J Bacteriol. 1987; 169(9):4320-6. PMC: 213747. DOI: 10.1128/jb.169.9.4320-4326.1987. View

15.

SCHELLENBERG K, COATNEY G . The influence of antimalarial drugs on nucleic acid synthesis in Plasmodium gallinaceum and Plasmodium berghei. Biochem Pharmacol. 1961; 6:143-52. DOI: 10.1016/0006-2952(61)90158-7. View

16.

Wang P, Read M, Sims P, Hyde J . Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol Microbiol. 1997; 23(5):979-86. DOI: 10.1046/j.1365-2958.1997.2821646.x. View

17.

Dallas W, Gowen J, Ray P, Cox M, Dev I . Cloning, sequencing, and enhanced expression of the dihydropteroate synthase gene of Escherichia coli MC4100. J Bacteriol. 1992; 174(18):5961-70. PMC: 207134. DOI: 10.1128/jb.174.18.5961-5970.1992. View

18.

Peterson D, Milhous W, Wellems T . Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc Natl Acad Sci U S A. 1990; 87(8):3018-22. PMC: 53825. DOI: 10.1073/pnas.87.8.3018. View

19.

TRAGER W, Jenson J . Cultivation of malarial parasites. Nature. 1978; 273(5664):621-2. DOI: 10.1038/273621a0. View

20.

Brooks D, Wang P, Read M, WATKINS W, Sims P, Hyde J . Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem. 1994; 224(2):397-405. DOI: 10.1111/j.1432-1033.1994.00397.x. View